21. Santiago D, Rosario Y, Melin K, et al. Brand-to-generic substitution of buprenorphine/naloxone sublingual film in Puerto Rico: a case study. P R Health Sci J. 2021;40 (4):192-194. 22.

Adverse events commonly observed with buprenorphine and naloxone sublingual film are oral hypoesthesia, glossodynia, oral mucosal erythema, headache, nausea, vomiting, hyperhidrosis, constipation ...

Alert FDA Clears First Generic Versions of Suboxone Sublingual Film Generic buprenorphine and naloxone sublingual film may increase access to treatment for opioid dependence, the agency said.